UM

Browse/Search Results:  1-10 of 17 Help

Selected(0)Clear Items/Page:    Sort:
A glycyrrhetinic acid-iridium(III) conjugate as a theranostic NIR probe for hepatocellular carcinoma with mitochondrial-targeting ability Journal article
Wang, Ling, Wang, Xueliang, Chen, Feng, Song, Ying Qi, Nao, Sang Cuo, Chan, Daniel Shiu Hin, Wong, Chun Yuen, Wang, Wanhe, Leung, Chung Hang. A glycyrrhetinic acid-iridium(III) conjugate as a theranostic NIR probe for hepatocellular carcinoma with mitochondrial-targeting ability[J]. European Journal of Medicinal Chemistry, 2024, 264, 115995.
Authors:  Wang, Ling;  Wang, Xueliang;  Chen, Feng;  Song, Ying Qi;  Nao, Sang Cuo; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:6.0/6.1 | Submit date:2024/02/22
Glycyrrhetinic Acid (Ga)  Hepatocellular Carcinoma  Iridium(Iii) Complex  Mitochondrial Targeting  Nir Imaging  Theranostic  
Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1/2 signaling Journal article
Yanfen Cheng, Xuemei Zhong, Xin Nie, Huan Gu, Xiaoping Wu, Renkai Li, Yihan Wu, Kongpeng Lv, George Pak-Heng Leung, Chaomei Fu, Simon Ming-Yuen Lee, Jinming Zhang, Jingjing Li. Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1/2 signaling[J]. Phytomedicine, 2023, 114, 154757.
Authors:  Yanfen Cheng;  Xuemei Zhong;  Xin Nie;  Huan Gu;  Xiaoping Wu; et al.
Favorite | TC[WOS]:20 TC[Scopus]:19  IF:6.7/6.2 | Submit date:2023/07/27
Angiogenesis  Breast Cancer Metastasis  Glycyrrhetinic Acid  Jnk1/2 Pathway  Tumor-associated Macrophages  
Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway Journal article
Cheng, Yanfen, Wu, Xiaoping, Nie, Xin, Wu, Yihan, Zhang, Chen, Lee, Simon Ming Yuen, Lv, Kongpeng, Leung, George Pak Heng, Fu, Chaomei, Zhang, Jinming, Li, Jingjing. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway[J]. PHYTOMEDICINE, 2022, 106.
Authors:  Cheng, Yanfen;  Wu, Xiaoping;  Nie, Xin;  Wu, Yihan;  Zhang, Chen; et al.
Favorite | TC[WOS]:36 TC[Scopus]:45  IF:6.7/6.2 | Submit date:2022/12/01
Cardiotoxicity  Doxorubicin  Glycyrrhetinic Acid  Nrf2  Oxidative Stress  
Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications Journal article
Tan, Dechao, Tseng, Hisa Hui Ling, Zhong, Zhangfeng, Wang, Shengpeng, Vong, Chi Teng, Wang, Yitao. Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications[J]. International Journal of Molecular Sciences, 2022, 23(19), 10988.
Authors:  Tan, Dechao;  Tseng, Hisa Hui Ling;  Zhong, Zhangfeng;  Wang, Shengpeng;  Vong, Chi Teng; et al.
Favorite | TC[WOS]:20 TC[Scopus]:23 | Submit date:2022/11/07
Glycyrrhizic Acid  Glycyrrhetinic Acid  Ammonium Glycyrrhizinate  Diammonium Glycyrrhizinate  Type 2 Diabetes Mellitus  Diabetic Complications  Insulin Resistance  Glucose Tolerance  
Dietary compound glycyrrhetinic acid suppresses tumor angiogenesis and growth by modulating antiangiogenic and proapoptotic pathways in vitro and in vivo Journal article
Li,Jingjing, Tang,Fan, Li,Renkai, Chen,Zhejie, Lee,Simon Ming Yuen, Fu,Chaomei, Zhang,Jinming, Leung,George Pak Heng. Dietary compound glycyrrhetinic acid suppresses tumor angiogenesis and growth by modulating antiangiogenic and proapoptotic pathways in vitro and in vivo[J]. Journal of Nutritional Biochemistry, 2020, 77.
Authors:  Li,Jingjing;  Tang,Fan;  Li,Renkai;  Chen,Zhejie;  Lee,Simon Ming Yuen; et al.
Favorite | TC[WOS]:31 TC[Scopus]:33  IF:4.8/5.4 | Submit date:2021/03/01
Antiangiogenesis  Apoptosis  Dietary Compound  Glycyrrhetinic Acid  Ovarian Cancer  
Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing beta-glucuronidase from Staphylococcus pasteuri 3I10 Journal article
Wei, Bin, Wang, Pan-Pan, Yan, Zhi-Xiang, Yan, Ru. Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing beta-glucuronidase from Staphylococcus pasteuri 3I10[J]. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2018, 102(21), 9193-9205.
Authors:  Wei, Bin;  Wang, Pan-Pan;  Yan, Zhi-Xiang;  Yan, Ru
Favorite | TC[WOS]:20 TC[Scopus]:20  IF:3.9/4.9 | Submit date:2019/01/17
Staphylococcus Pasteuri  Bacterial Beta-glucuronidase  Glycyrrhizin  Glycyrrhetinic Acid  Deglucuronidation  Homology Modeling  
Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing β-glucuronidase from Staphylococcus pasteuri 3I10 Journal article
Bin Wei, Pan-Pan Wang, Zhi-Xiang Yan, Ru Yan. Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing β-glucuronidase from Staphylococcus pasteuri 3I10[J]. Applied Microbiology and Biotechnology, 2018, 102(21), 9193–9205.
Authors:  Bin Wei;  Pan-Pan Wang;  Zhi-Xiang Yan;  Ru Yan
Favorite | TC[WOS]:20 TC[Scopus]:20  IF:3.9/4.9 | Submit date:2019/01/15
Staphylococcus Pasteuri  Β-glucuronidases  Deglucuronidation  Glycyrrhizin  Glycyrrhetinic Acid  Homology Modeling  Gut Microbiota  
Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma Efficacy Journal article
Zhang, Jinming, Zheng, Yifeng, Xie, Xi, Wang, Lan, Su, Ziren, Wang, Yitao, Leong, Kam W., Chen, Meiwan. Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma Efficacy[J]. MOLECULAR PHARMACEUTICS, 2017, 14(11), 3644-3659.
Authors:  Zhang, Jinming;  Zheng, Yifeng;  Xie, Xi;  Wang, Lan;  Su, Ziren; et al.
View | Adobe PDF | Favorite | TC[WOS]:29 TC[Scopus]:31  IF:4.5/4.6 | Submit date:2018/10/30
Tumor-targeting  Glycyrrhetinic Acid  Ph-sensitive  Tat Exposure  Mixed Micelles  
Codelivery of Doxorubicin and shAkt1 by Poly(ethylenimine)-Glycyrrhetinic Acid Nanoparticles to Induce Autophagy-Mediated Liver Cancer Combination Therapy Journal article
Feng-Zhen Wang, Lei Xing, Zheng-hai Tang, Jin-Jian Lu, Peng-Fei Cui, Jian-Bing Qiao, Lei Jiang, Hu-Lin Jiang, Li Zong. Codelivery of Doxorubicin and shAkt1 by Poly(ethylenimine)-Glycyrrhetinic Acid Nanoparticles to Induce Autophagy-Mediated Liver Cancer Combination Therapy[J]. Molecular Pharmaceutics, 2016, 13(4), 1298-1307.
Authors:  Feng-Zhen Wang;  Lei Xing;  Zheng-hai Tang;  Jin-Jian Lu;  Peng-Fei Cui; et al.
Favorite | TC[WOS]:54 TC[Scopus]:53 | Submit date:2018/12/28
Autophagy  Combination Therapy  Glycyrrhetinic Acid  Liver Cancer Targeting  Self-assembled  
Codelivery of Doxorubicin and shAkt1 by Poly ethylenimine)−Glycyrrhetinic Acid Nanoparticles To Induce Autophagy-Mediated Liver Cancer Combination Therapy Journal article
Wang, FZ, Xing, L, Tang, ZH, Lu, J., Cui, PF, Qiao, JB, Jiang, L, Jiang, HL, Zhong, L. Codelivery of Doxorubicin and shAkt1 by Poly ethylenimine)−Glycyrrhetinic Acid Nanoparticles To Induce Autophagy-Mediated Liver Cancer Combination Therapy[J]. Molecular Pharmaceutics, 2016, 1298-1307.
Authors:  Wang, FZ;  Xing, L;  Tang, ZH;  Lu, J.;  Cui, PF; et al.
Favorite |   IF:4.5/4.6 | Submit date:2022/08/26
combination therapy  self-assembled  glycyrrhetinic acid  liver cancer targeting  autophagy